These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 35113458)

  • 21. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular RelB interacts with the transactivator Tat and enhance HIV-1 expression.
    Wang M; Yang W; Chen Y; Wang J; Tan J; Qiao W
    Retrovirology; 2018 Sep; 15(1):65. PubMed ID: 30241541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of HCV on basal and tat-induced HIV LTR activation.
    Sengupta S; Powell E; Kong L; Blackard JT
    PLoS One; 2013; 8(6):e64956. PubMed ID: 23762271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between TGFbeta signaling proteins and C/EBP controls basal and Tat-mediated transcription of HIV-1 LTR in astrocytes.
    Coyle-Rink J; Sweet T; Abraham S; Sawaya B; Batuman O; Khalili K; Amini S
    Virology; 2002 Aug; 299(2):240-7. PubMed ID: 12202226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toll-like receptor-3 mediates HIV-1 transactivation via NFκB and JNK pathways and histone acetylation, but prolonged activation suppresses Tat and HIV-1 replication.
    Bhargavan B; Woollard SM; Kanmogne GD
    Cell Signal; 2016 Feb; 28(2):7-22. PubMed ID: 26569339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An emerging and variant viral promoter of HIV-1 subtype C exhibits low-level gene expression noise.
    Ali H; Bhange D; Mehta K; Gohil Y; Prajapati HK; Byrareddy SN; Buch S; Ranga U
    Retrovirology; 2021 Sep; 18(1):27. PubMed ID: 34538278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long Noncoding RNA uc002yug.2 Activates HIV-1 Latency through Regulation of mRNA Levels of Various RUNX1 Isoforms and Increased Tat Expression.
    Huan C; Li Z; Ning S; Wang H; Yu XF; Zhang W
    J Virol; 2018 May; 92(9):. PubMed ID: 29491162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study of transactivation effect on transcription by Tat-TAR-system of human immunodeficiency virus type 1 (HIV-1) in non-lymphoid cells HEK293 and Calu-1].
    Mingaleeva RN; Chernov IP; Kopantsev EP; Stukacheva EA; Skaptsova NV; Sverdlov ED
    Mol Gen Mikrobiol Virusol; 2009; (2):11-5. PubMed ID: 19517804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of Egr-1 expression in astrocytes by HIV-1 Tat: new insights into astrocyte-mediated Tat neurotoxicity.
    Fan Y; Zou W; Green LA; Kim BO; He JJ
    J Neuroimmune Pharmacol; 2011 Mar; 6(1):121-9. PubMed ID: 20414733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
    Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
    J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
    Murphy KM; Sweet MJ; Ross IL; Hume DA
    J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of monocyte chemoattractant protein-1 (MCP-1/CCL2) gene expression by human immunodeficiency virus-1 Tat in human astrocytes is CDK9 dependent.
    Khiati A; Chaloin O; Muller S; Tardieu M; Horellou P
    J Neurovirol; 2010 Mar; 16(2):150-67. PubMed ID: 20370601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of transcriptional transactivation and restriction of human immunodeficiency virus type I replication in an astrocytic glial cell.
    Niikura M; Dornadula G; Zhang H; Mukhtar M; Lingxun D; Khalili K; Bagasra O; Pomerantz RJ
    Oncogene; 1996 Jul; 13(2):313-22. PubMed ID: 8710370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosome-associated release, uptake, and neurotoxicity of HIV-1 Tat protein.
    Rahimian P; He JJ
    J Neurovirol; 2016 Dec; 22(6):774-788. PubMed ID: 27173397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tat expression led to increased histone 3 tri-methylation at lysine 27 and contributed to HIV latency in astrocytes through regulation of MeCP2 and Ezh2 expression.
    Liu Y; Niu Y; Li L; Timani KA; He VL; Sanburns C; Xie J; He JJ
    J Neurovirol; 2019 Aug; 25(4):508-519. PubMed ID: 31020497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site.
    Schafer SL; Vlach J; Pitha PM
    J Virol; 1996 Oct; 70(10):6937-46. PubMed ID: 8794337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes.
    Madlala P; Mkhize Z; Naicker S; Khathi SP; Maikoo S; Gopee K; Dong KL; Ndung'u T
    PLoS Pathog; 2023 Jun; 19(6):e1011194. PubMed ID: 37307292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probabilistic control of HIV latency and transactivation by the Tat gene circuit.
    Cao Y; Lei X; Ribeiro RM; Perelson AS; Liang J
    Proc Natl Acad Sci U S A; 2018 Dec; 115(49):12453-12458. PubMed ID: 30455316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2.
    Dal Monte P; Landini MP; Sinclair J; Virelizier JL; Michelson S
    AIDS; 1997 Mar; 11(3):297-303. PubMed ID: 9147420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.